Europe PMC requires Javascript to function effectively.

Either your web browser doesn't support Javascript or it is currently turned off. In the latter case, please turn on Javascript support in your web browser and reload this page.

Search life-sciences literature (45,100,050 articles, preprints and more)

Suggested authors matching "AUTH:Fabi A" with an ORCID

Alessandra Fabi
No affiliation detected
3
Publications
180
Citations
View profile

Search results

1-25 of 353 results

Sort by:

Relevance ^{Relevance: This is determined based on a ranking of criteria including term frequency, rarity of term, recency of article, whether there is a Title or Author field match, etc.}

Times cited

Date

1 2 3 Next ...

The journey of patients affected by metastatic hormone receptor-positive/HER2-negative breast cancer from CDK 4/6 inhibitors to second-line treatment: A real-world analysis of 701 patients enrolled in the GIM14/BIOMETA study.
Molinelli C, Bruzzone M, Blondeaux E, Ruelle T, Lanzavecchia C, De Laurentiis M, Russo S, Riccardi F, Sini V, Cognetti F, Arpino G, Fabi A, Pugliese P, Collovà E, Fontana A, Puglisi F, Bighin C, Lambertini M, Del Mastro L
Eur J Cancer, 213:115113, 04 Nov 2024
Cited by: 0 articles | PMID: 39536433
Add to export list
Follow-up of early breast cancer in a public health system: A 2024 AIGOM consensus project.
Gori S, De Rose F, Ferro A, Fabi A, Angiolini C, Azzarello G, Cancian M, Cinquini M, Arecco L, Aristei C, Bernardi D, Biganzoli L, Cariello A, Cortesi L, Cretella E, Criscitiello C, De Giorgi U, Carmen De Santis M, Deledda G, [...] Italian Association of Multidisciplinary Oncology Groups (AIGOM)
Cancer Treat Rev, 131:102832, 05 Oct 2024
Cited by: 0 articles | PMID: 39437511
Add to export list Review
Transient splicing inhibition causes persistent DNA damage and chemotherapy vulnerability in triple-negative breast cancer.
Caggiano C, Petrera V, Ferri M, Pieraccioli M, Cesari E, Di Leone A, Sanchez MA, Fabi A, Masetti R, Naro C, Sette C
Cell Rep, 43(9):114751, 13 Sep 2024
Cited by: 0 articles | PMID: 39276346
Add to export list
The value of perforator flap reconstruction in painful soft tissue calcifications.
Kouba L, Fabi A, Glatz K, Thoma A, Lariu A, Burger M, Schweizer T, Schaefer DJ, Kappos EA
Clin Exp Med, 24(1):189, 13 Aug 2024
Cited by: 0 articles | PMID: 39136799 | PMCID: PMC11322213
Add to export list Review
This article is in the Europe PMC Open access subset. Refer to the copyright information in the article for licensing details.
Free full text in Europe PMC
Parp-inhibitors in the therapeutic landscape of breast cancer patients with BRCA1 and BRCA2 pathogenic germline variants: An Italian consensus paper and critical review.
Zambelli A, Cortesi L, Gaudio M, Arpino G, Bianchini G, Caruso F, Cinieri S, Curigliano G, Del Mastro L, De Placido S, Fabi A, Fortunato L, Generali D, Gennari A, Gori S, Grandi G, Guarneri V, Klinger M, Livi L, [...] De Laurentiis M
Cancer Treat Rev, 130:102815, 21 Aug 2024
Cited by: 0 articles | PMID: 39208751
Add to export list Review
Author Correction: Clinical impact of drug-drug interactions on abemaciclib in the real-world experience of AB-ITALY study.
Scagnoli S, Pisegna S, Toss A, Caputo R, De Laurentiis M, Palleschi M, de Giorgi U, Cortesi E, Fabbri A, Fabi A, Paris I, Orlandi A, Curigliano G, Criscitiello C, Garrone O, Tomasello G, D'Auria G, Vici P, Ricevuto E, [...] Botticelli A
NPJ Breast Cancer, 10(1):68, 02 Aug 2024
Cited by: 0 articles | PMID: 39095493 | PMCID: PMC11297323
Add to export list
This article is in the Europe PMC Open access subset. Refer to the copyright information in the article for licensing details.
Free full text in Europe PMC
Fatigue in patients with metastatic breast cancer undergoing single-agent taxane-based chemotherapy: a real-world data global network.
Fabi A, Gavioli EM, Wakade R, Spera MC, Miracle S, Valveny N, Butler E, DePizzol M, Ruffini PA, Allegretti M
Ther Adv Med Oncol, 16:17588359241240972, 26 Jul 2024
Cited by: 0 articles | PMID: 39072243 | PMCID: PMC11282541
Add to export list
This article is in the Europe PMC Open access subset. Refer to the copyright information in the article for licensing details.
Free full text in Europe PMC
Efficacy of adjuvant chemotherapy schedules for breast cancer according to body mass index: results from the phase III GIM2 trial.
Poggio F, Blondeaux E, Tagliamento M, Perachino M, Nardin S, Conte B, Giuliano M, Arpino G, De Laurentiis M, Gravina A, Bisagni G, Rimanti A, Turletti A, Nisticò C, Magnolfi E, Gasparro S, Fabi A, Garrone O, Alicicco MG, [...] Del Mastro L
ESMO Open, 9(8):103650, 08 Aug 2024
Cited by: 2 articles | PMID: 39121814 | PMCID: PMC11362642
Add to export list
This article is in the Europe PMC Open access subset. Refer to the copyright information in the article for licensing details.
Free full text in Europe PMC
Outcomes of Radiotherapy in Oligoprogressive Breast Cancer.
Marazzi F, Masiello V, Orlandi A, Moschella F, Chiesa S, Di Leone A, Garufi G, Mazzarella C, Sanchez AM, Casa C, Bucaro A, De Lauretis F, Borghesan N, Tagliaferri L, Franceschini G, Bria E, Masetti R, Fabi A, Aristei C, [...] Gambacorta MA
J Pers Med, 14(8):805, 29 Jul 2024
Cited by: 0 articles | PMID: 39201997 | PMCID: PMC11355129
Add to export list
This article is in the Europe PMC Open access subset. Refer to the copyright information in the article for licensing details.
Free full text in Europe PMC
Clinical impact of drug-drug interactions on abemaciclib in the real-world experience of AB-ITALY study.
Scagnoli S, Pisegna S, Toss A, Caputo R, De Laurentiis M, Palleschi M, de Giorgi U, Cortesi E, Fabbri A, Fabi A, Paris I, Orlandi A, Curigliano G, Criscitiello C, Garrone O, Tomasello G, D'Auria G, Vici P, Ricevuto E, [...] Botticelli A
NPJ Breast Cancer, 10(1):58, 17 Jul 2024
Cited by: 1 article | PMID: 39019916 | PMCID: PMC11254918
Add to export list
This article is in the Europe PMC Open access subset. Refer to the copyright information in the article for licensing details.
Free full text in Europe PMC
Multigenic panels in breast cancer: Clinical utility and management of patients with pathogenic variants other than BRCA1/2.
Fabi A, Cortesi L, Duranti S, Cordisco EL, Di Leone A, Terribile D, Paris I, de Belvis AG, Orlandi A, Marazzi F, Muratore M, Garganese G, Fuso P, Paoletti F, Dell'Aquila R, Minucci A, Scambia G, Franceschini G, Masetti R, Genuardi M
Crit Rev Oncol Hematol, 201:104431, 06 Jul 2024
Cited by: 0 articles | PMID: 38977141
Add to export list Review
Monitoring changing patterns in HER2 addiction by liquid biopsy in advanced breast cancer patients.
Giordani E, Allegretti M, Sinibaldi A, Michelotti F, Ferretti G, Ricciardi E, Ziccheddu G, Valenti F, Di Martino S, Ercolani C, Giannarelli D, Arpino G, Gori S, Omarini C, Zambelli A, Bria E, Paris I, Buglioni S, Giacomini P, Fabi A
J Exp Clin Cancer Res, 43(1):182, 29 Jun 2024
Cited by: 0 articles | PMID: 38951853 | PMCID: PMC11218356
Add to export list
This article is in the Europe PMC Open access subset. Refer to the copyright information in the article for licensing details.
Free full text in Europe PMC
Trastuzumab Deruxtecan in brain metastases from breast cancer: outcome analysis of real life population
Rossi A, Fabi A, Caputo R, Pisegna S, Scagnoli S, Pantano F, D'Auria G, Fedele P, Fabbri A, Vernieri C, Palleschi M, Carbognin L, Ferretti G, Monte ED, Paris I, Pavese F, Garrone O, Franco A, De Laurentiis M, [...] Botticelli A
Research Square, 11 Jun 2024
Cited by: 0 articles | PPR: PPR865713
Add to export list Preprint v1
Long-Term Safety of Level II Oncoplastic Surgery after Neoadjuvant Treatment for Locally Advanced Breast Cancer: A 20-Year Experience.
Sanchez AM, De Lauretis F, Bucaro A, Borghesan N, Pirrottina CV, Franco A, Scardina L, Giannarelli D, Millochau JC, Parapini ML, Di Leone A, Marazzi F, Orlandi A, Palazzo A, Fabi A, Masetti R, Franceschini G
J Clin Med, 13(13):3665, 23 Jun 2024
Cited by: 0 articles | PMID: 38999231
Add to export list
Long-Term Safety of Level II Oncoplastic Surgery after Neoadjuvant Treatment for Locally Advanced Breast Cancer: A 20-Year Experience
Sanchez A, De Lauretis F, Bucaro A, Borghesan N, Pirrottina C, Franco A, Scardina L, Giannarelli D, Millochau J, Parapini M, Di Leone A, Marazzi F, Orlandi A, Palazzo A, Fabi A, Masetti R, Franceschini G
J Clin Med, 13(13), 23 Jun 2024
Cited by: 0 articles | PMCID: PMC11242857
Add to export list
This article is in the Europe PMC Open access subset. Refer to the copyright information in the article for licensing details.
Free full text in Europe PMC
Male breast cancer: a multicenter study to provide a guide for proper management.
Lissidini G, Nicosia L, Sargenti M, Cucchi MC, Fabi A, Falco G, Gardani M, Grilz G, Maugeri I, Murgo R, Neri A, Pellini F, Sensi C, Scomersi S, Taffurelli M, Bagnardi V, Oriecuia C, Pagan E, Sangalli C, [...] Galimberti V
Breast Cancer Res Treat, 208(1):29-40, 19 Jun 2024
Cited by: 1 article | PMID: 38896332
Add to export list
Impact of hormone receptor status and tumor subtypes of breast cancer in young BRCA carriers.
Arecco L, Bruzzone M, Bas R, Kim HJ, Di Meglio A, Bernstein-Molho R, Hilbers FS, Pogoda K, Carrasco E, Punie K, Bajpai J, Agostinetto E, Lopetegui-Lia N, Partridge AH, Phillips KA, Toss A, Rousset-Jablonski C, Curigliano G, Renaud T, [...] Lambertini M
Ann Oncol, 35(9):792-804, 20 Jun 2024
Cited by: 0 articles | PMID: 38908482
Add to export list
Simultaneous Integrated Boost (Sib) Intensity-Modulated Radiotherapy for Treatment of Bone Metastases: Analysis of a Breast Cancer Cohort
Marazzi F, Masiello V, Fabi A, Manfrida S, Corvari B, Lancellotta V, Mazzarella C, Longo S, De Angeli M, Moschella F, Di Leone A, Orlandi A, Bracci S, Colloca GF, Massaccesi M, Boldrini L, Tagliaferri L, Franceschini G, Bria E, [...] CELLINI F
Preprints.org, 10 Jun 2024
Cited by: 0 articles | PPR: PPR865560
Add to export list Preprint v1
Navigating practical challenges in immunotherapy for metastatic triple negative breast cancer.
Licata L, Dieci MV, De Angelis C, Marchiò C, Miglietta F, Cortesi L, Fabi A, Schmid P, Cortes J, Pusztai L, Bianchini G, Curigliano G
Cancer Treat Rev, 128:102762, 16 May 2024
Cited by: 1 article | PMID: 38776613
Add to export list Review
Clinico-pathological predictors of radiologic complete response to first-line anti-HER2 therapy in metastatic breast cancer: insights from real-world data of a nationwide cohort
Cucciniello L, Blondeaux E, Bighin C, Gasparro S, Russo S, Dri A, Pugliese P, Fontana A, Cortesi E, Ferzi A, Riccardi F, Sini V, Boni L, Fabi A, Montemurro F, De Laurentiis M, Arpino G, Mastro LD, Gerratana L, Puglisi F
Research Square, 15 May 2024
Cited by: 0 articles | PPR: PPR853431
Add to export list Preprint v1
The role of body composition in neurological and hematologic toxicity in breast cancer patients undergoing neoadjuvant chemotherapy. The COMBOTOX study
Leone AD, Filippone A, Maggiore C, Rossi MM, Rossi C, Micco AD, Forcina L, Franco A, Ionta L, Fabi A, Paris I, Scardina L, Sanchez AM, Pafundi PC, Franceschini G, Masetti R, Magno S
Research Square, 07 May 2024
Cited by: 0 articles | PPR: PPR849285
Add to export list Preprint v1
Improving quality of life after breast cancer: a comparison of two microsurgical treatment options for breast cancer-related lymphedema (BCRL).
Seidenstuecker K, Fertsch S, Ghazaleh AA, Fabi A, Stoffel J, Bukowiecki J, Wolter A, Aghlmandi S, Nadella A, Halbeisen FS, Andree C, Haug MD, Schaefer DJ, Handschin TM, Kappos EA
Clin Exp Med, 24(1):82, 23 Apr 2024
Cited by: 0 articles | PMID: 38653874 | PMCID: PMC11039536
Add to export list
This article is in the Europe PMC Open access subset. Refer to the copyright information in the article for licensing details.
Free full text in Europe PMC
Preventing Bone Loss in Breast Cancer Patients: Designing a Personalized Clinical Pathway in a Large-Volume Research Hospital.
Amar ID, Franceschini G, Nero C, Pasqua I, Paris I, Orlandi A, Gori S, Fabi A, Garganese G, Scambia G, Villa P
J Pers Med, 14(4):371, 30 Mar 2024
Cited by: 0 articles | PMID: 38672998 | PMCID: PMC11051440
Add to export list
This article is in the Europe PMC Open access subset. Refer to the copyright information in the article for licensing details.
Free full text in Europe PMC
Real-World Outcomes of Trastuzumab Deruxtecan in Patients With HER2+ Metastatic Breast Cancer: The DE-REAL Study.
Botticelli A, Caputo R, Scagnoli S, Pisegna S, De Laurentiis M, Curigliano G, Lambertini M, Pantano F, Palazzo A, Paris I, Vernieri C, Tedesco B, Giampaglia M, Palleschi M, Ballatore Z, Alesini D, D'Auria G, Fabbri A, Rossi L, [...] Fabi A
Oncologist, 29(4):303-310, 01 Apr 2024
Cited by: 2 articles | PMID: 37995313 | PMCID: PMC10994255
Add to export list
This article is in the Europe PMC Open access subset. Refer to the copyright information in the article for licensing details.
Free full text in Europe PMC
Corrigendum to "Breaking barriers in triple negative breast cancer (TNBC) - Unleashing the power of antibody-drug conjugates (ADCs)" [Cancer Treatment Reviews 123 (2024) 102672].
Dri A, Arpino G, Bianchini G, Curigliano G, Danesi R, De Laurentiis M, Del Mastro L, Fabi A, Generali D, Gennari A, Guarneri V, Santini D, Simoncini E, Zamagni C, Puglisi F
Cancer Treat Rev, 125:102714, 16 Mar 2024
Cited by: 0 articles | PMID: 38493647
Add to export list

1-25 of 353 results

1 2 3 Next ...

Search life-sciences literature (45,100,050 articles, preprints and more)

Suggested authors matching "AUTH:Fabi A" with an ORCID Suggested authors have linked their articles in Europe PMC to their ORCID iD. Up to two suggested authors with a matching surname and initial are shown, ordered by the total number of publications they have in Europe PMC.

Search results

Partnerships & funding

Suggested authors matching "AUTH:Fabi A" with an ORCID